Could I really double my money with these 2 growth stocks?

Growth stocks have taken big hits in 2022. These two shares are no exception, but I think both have considerable potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Growth stocks certainly haven’t been in fashion this year. With inflation and interest rates rising, investors have sought value and dividends.

But after a sustained fall impacted very many growth stocks over the past six to 10 months, valuations have become much more attractive.

I’m looking at two stocks, NIO (NASDAQ:NIO) and Darktrace (LSE:DARK), to boost my portfolio. I’ve already bought both, but at their current prices, I’m looking to buy more. I’m also wondering whether I can double my money with these two stocks.

NIO

NIO is down 58% over the past 12 months. In fact, it fell further in April, before rising in May.

NIO is one of the most promising EV makers in the world. While it’s not anticipated to turn a profit until 2024, it’s trading with a price-to-sales (P/S) ratio of just 4.5. That means it’s much cheaper than US peers like Tesla (14) or Rivian and Lucid that both trade with P/S ratios above 100.

Based on this metric, I can see that if the NIO share price were to double, it would still be cheaper, based on its P/S, than sector leader Tesla. NIO is currently valued at $18 a share. If it were to reach $36, it would remain far below its year high of $55.

So, could I double my money with NIO stock? It’s certainly possible. I’m actually very bullish on NIO because of its impressive range of EVs and use of battery swapping technology. The latter allows users to swap their empty batteries for full ones at NIO garages in a matter of minutes.

One concern is Chinese Covid lockdowns which could hurt production and demand.

I bought NIO stock when it dipped in May, but would buy more at the current price.

Darktrace

Darktrace fell considerably in May. It has since recovered and is up nearly 10% against 12 months ago. But it still trades at less than half of its year high. Investors have struggled to value this stock, which has huge potential.

Like a number of its peers, the AI cyber-security firm appears to be benefiting from a renewed focus on cybersecurity following Russia’s invasion of Ukraine.

Darktrace is on an impressive growth curve, although some analysts have questioned its sustainability. Total revenue increased from $79.4m in the year to June 2018, to $281m in the year to June 2021. Revenue for latest four quarters is $347.5m. 

So, could I double my money with Darktrace? Well, Jefferies has a 730p target price on the stock, almost double the current share price. Other brokers have similar targets.

It also trades with multiples considerably below its peers. Its P/S ratio is around 9, while peer CrowdStrike has a P/S ratio of around 22. So even if the Darktrace share price doubled, it would still appear cheaper than several peers.

I’m bullish on Darktrace, although some analysts are concerned about increasing competition in the space.

It’s certainly possible that these two stocks’ prices could double based on their peers’ valuations and even their own valuations over the past year. They’re both on an impressive growth curve but need to sustain that growth to drive the share prices much higher.

That growth isn’t guaranteed and there are hurdles ahead, but I’d still buy both.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

James Fox owns shares in NIO and Darktrace. The Motley Fool UK has recommended CrowdStrike Holdings, Inc. and Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »